Cebix Inc.
This article was originally published in Start Up
Executive Summary
Cebix Inc. is developing a disease-modifying replacement peptide for complications associated with diabetes. Unlike other products simply directed at symptomatic relief, Cebix thinks its long-acting form of C-peptide has the potential to reverse the chronic complications of diabetes.